glucagon has been researched along with oxymetazoline in 5 studies
| Studies (glucagon) | Trials (glucagon) | Recent Studies (post-2010) (glucagon) | Studies (oxymetazoline) | Trials (oxymetazoline) | Recent Studies (post-2010) (oxymetazoline) |
|---|---|---|---|---|---|
| 26,039 | 1,498 | 3,054 | 738 | 128 | 159 |
| Protein | Taxonomy | glucagon (IC50) | oxymetazoline (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.578 | |
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 3.261 | |
| Muscarinic acetylcholine receptor M5 | Homo sapiens (human) | 1.332 | |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.023 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 0.2 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 1.273 | |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | 2.633 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.0056 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 2.844 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 1.285 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.578 | |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 0.0056 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 3.056 | |
| 5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 1.67 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hara, M; Ogawa, A; Sasaki, H; Sato, N; Suda, K; Takahashi, K; Wada, K; Wakasugi, K; Yamatani, K | 1 |
| Hara, M; Sasaki, H; Sato, N; Takahashi, K; Yamatani, K | 1 |
| Fukata, J; Kasting, NW; Martin, JB | 1 |
| Ogihara, M | 1 |
| Marubashi, S; Saito, K; Sasaki, H; Sato, N; Takahashi, K; Wakasugi, K; Yamatani, K | 1 |
5 other study(ies) available for glucagon and oxymetazoline
| Article | Year |
|---|---|
Two types of hormone-responsive adenylate cyclase in the rat liver.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Colforsin; Glucagon; Glucose; In Vitro Techniques; Insulin; Kinetics; Liver; Liver Glycogen; Male; Oxymetazoline; Perfusion; Rats; Rats, Inbred Strains; Secretin | 1987 |
Dissociation of the alpha-adrenergic inhibitory effects on glucagon- and secretin-stimulated bile volume and on cyclic adenosine monophosphate production in the isolated perfused rat liver.
Topics: Adrenergic alpha-Agonists; Animals; Bile; Cyclic AMP; Glucagon; Glucose; In Vitro Techniques; Liver; Male; Oxymetazoline; Phenylephrine; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Secretin | 1985 |
Somatostatin release from the median eminence of unanesthetized rats: lack of correlation with pharmacologically suppressed growth hormone secretion.
Topics: Animals; Escherichia coli; Glucagon; Growth Hormone; Lipopolysaccharides; Male; Median Eminence; Neurotensin; Oxymetazoline; Pituitary Gland, Anterior; Rats; Somatostatin | 1985 |
Expression of alpha 2-receptor-mediated responses by insulin in primary culture of rat hepatocytes.
Topics: Animals; Cells, Cultured; Clonidine; Colforsin; Cyclic AMP; Cycloheximide; Drug Interactions; Glucagon; Glucose; Insulin; Liver; Male; Oxymetazoline; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2; Time Factors | 1995 |
Catecholamine-induced cAMP response in streptozotocin-induced diabetic rat liver.
Topics: Adipose Tissue; Animals; Colforsin; Cyclic AMP; Diabetes Mellitus, Experimental; Emaciation; Epinephrine; Glucagon; Glucose; Insulin; Isoproterenol; Lactates; Lactic Acid; Liver; Male; Oxymetazoline; Phenylephrine; Propranolol; Pyruvates; Pyruvic Acid; Rats; Receptors, Adrenergic, beta; Streptozocin | 1994 |